| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 62.84▼ | 62.85▼ | 62.97▼ | 60.22▲ | 58.61▲ |
| MA10 | 62.86▼ | 63.22▼ | 62.59▲ | 59.03▲ | 52.54▲ |
| MA20 | 62.84▼ | 62.35▲ | 61.06▲ | 57.48▲ | 39.32▲ |
| MA50 | 63.31▼ | 60.36▲ | 59.66▲ | 49.58▲ | N/A |
| MA100 | 61.91▲ | 59.62▲ | 58.40▲ | 36.90▲ | N/A |
| MA200 | 60.46▲ | 58.37▲ | 55.95▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.150▼ | 0.154▲ | -0.067▼ | 2.276▲ |
| RSI | 43.479▼ | 55.291▲ | 60.691▲ | 67.277▲ | 87.978▲ |
| STOCH | 21.779 | 21.939 | 63.528 | 58.736 | 89.050▲ |
| WILL %R | -99.180▼ | -56.709 | -43.629 | -23.472▲ | -6.542▲ |
| CCI | -187.366▼ | -48.241 | 42.198 | 193.391▲ | 100.695▲ |
| CDL | $PVLA Shooting Star Candlestick Pattern Detected | Set Alert |
|
Monday, September 29, 2025 07:00 AM
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it will expand development of its investigational therapy QTORIN™ 3.9% rapamycin anhydrous gel into clinically significant ...
|
|
Sunday, September 28, 2025 05:00 AM
Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it has completed TOIVA, a Phase 2 proof-of-concept trial of QTORIN™ 3.9% rapamycin anhydrous gel, for the treatment of cutaneous venous ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 62.27 | 65.57 | 62.02 | 62.69 | 237,700 |
| 29/09/25 | 60.10 | 63.39 | 59.16 | 62.25 | 278,600 |
| 26/09/25 | 58.79 | 61.00 | 58.16 | 59.59 | 200,700 |
| 25/09/25 | 60.03 | 60.03 | 57.38 | 57.69 | 119,553 |
| 24/09/25 | 57.06 | 61.30 | 56.545 | 58.87 | 246,600 |
| 23/09/25 | 58.98 | 59.60 | 56.56 | 56.69 | 262,500 |
| 22/09/25 | 59.6452 | 60.25 | 57.945 | 58.71 | 165,093 |
| 19/09/25 | 59.19 | 63.12 | 56.22 | 58.24 | 326,800 |
| 18/09/25 | 56.29 | 61.40 | 56.29 | 59.04 | 234,700 |
| 17/09/25 | 55.50 | 57.84 | 54.48 | 56.57 | 237,032 |
|
|
||||
|
|
||||
|
|